Clean Science & Technology Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹7,865 Cr
- P/E
- 33.76
- ROE
- 15.32%
- PEG
- -4.20
- Price to sales
- 8.02
- Debt to equity
- 0.00
- 52W high / low
- ₹1,050 / ₹656
- Sales growth (5Y)
- 13.30%
- EBITDA margin
- 35.80%
- Net profit margin
- 24.03%
- Promoter holding
- 51.29%
- Sales (last year)
- ₹982 Cr
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]
Guidance scorecard · Q1 FY27 call
What Clean Science & Technology Ltd's management guided
and where it ranks in Chemicals & Petrochemicals
Chemicals & Petrochemicals
RevenueQ1 FY27 call
10–20%- HALS business revenue is expected to grow to INR 250-300 crores annually, contributing around 30-35% of overall revenue growth in FY27, with export constituting nearly 50% of HALS sales.
- HALS volume for the year is targeted above 3,000 metric tons, with consistent scale-up expected over next 2-3 years.
- EBITDA margins for HALS are projected to improve due to higher-grade product mix and operational efficiencies.
- Performance Chemical 2 plant commercialization expected by Q3 FY27, with revenues anticipated from Q1 FY28 after stabilization.
- Strategic collaborations (Geneus Chem, Kemin) expected to enhance revenue streams, including an incremental INR 300 crores over 4 years from Geneus tie-up.
2 more points from Clean Science & Technology Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Clean Science & Technology Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- INR 100 crores capex invested in subsidiary Clean Fino Chem Limited; all future products and new lines to be developed here.
- Geneus Chem tie-up involves a capex of about INR 25 crores for a new plant to produce advanced HALS products, expected to start production in Q3 FY27.
- Additional capacity expansion is planned to meet increased demand from Kemin contract; the process has already started.
2 more points from Clean Science & Technology Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what Clean Science & Technology Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- Siddharth Sikchi stated that exports to the U.S. have been very steady despite tariff and China competition issues, indicating ongoing strong demand.
- A strategic 5-year contract with Kemin ensures assured volumes for certain key products, implying a secured portion of the order book with a significant global customer.
- The HALS business is expected to grow, with a revenue target of INR 250-300 crores for FY27, showing increasing order flow.
2 more points from Clean Science & Technology Ltd's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹263 Cr | 3.4 | |
| 2 | 40%+ | Flat | ₹4,375 Cr | 83.7 | |
| 3 | 40%+ | Flat | ₹3,259 Cr | 4.0 | |
| 4 | 40%+ | Flat | ₹145 Cr | 15.9 | |
| 5 | 20–40% | Up 2%+ | ₹1.81L Cr | 90.9 | |
| 6 | 20–40% | Up 2%+ | ₹48,366 Cr | 78.3 |
Sign up free to see every company in the sector ranking and track Clean Science & Technology Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Clean Science & Technology Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Clean Science & Technology Ltd
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 74.98% | 74.98% | 74.98% | 74.97% | 74.97% | 74.96% | 74.96% | 50.96% | 50.96% | 51.29% | 51.29% | 51.29% |
| FIIs + | 5.92% | 5.88% | 6.05% | 5.83% | 5.98% | 6.07% | 6.21% | 11.14% | 10.01% | 13.38% | 13.37% | 13.72% |
| DIIs + | 5.13% | 5.04% | 4.55% | 4.77% | 5.46% | 5.77% | 5.92% | 18.97% | 19.76% | 17.14% | 16.23% | 15.10% |
| Government + | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public + | 13.98% | 14.11% | 14.42% | 14.43% | 13.59% | 13.21% | 12.91% | 18.91% | 19.26% | 18.17% | 19.11% | 19.88% |
| No. of Shareholders | 2,78,653 | 2,79,395 | 2,73,841 | 2,54,629 | 2,46,798 | 2,37,016 | 2,25,484 | 2,39,974 | 2,43,606 | 2,37,113 | 2,41,947 | 2,37,681 |
Financials of Clean Science & Technology Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 188 | 181 | 195 | 228 | 224 | 238 | 241 | 264 | 243 | 245 | 220 | 249 | 268 |
| Expenses + | 112 | 106 | 108 | 133 | 129 | 148 | 142 | 159 | 143 | 158 | 147 | 153 | 172 |
| Operating Profit | 76 | 75 | 87 | 95 | 95 | 90 | 98 | 105 | 100 | 87 | 72 | 96 | 96 |
| OPM % | 40% | 41% | 44% | 42% | 42% | 38% | 41% | 40% | 41% | 36% | 33% | 38% | 36% |
| Other Income + | 13 | 6 | 8 | 14 | 10 | 11 | 5 | 12 | 13 | 7 | 10 | 3 | 22 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 11 | 11 | 13 | 16 | 18 | 18 | 17 | 19 | 19 | 19 | 21 | 21 |
| Profit before tax | 79 | 69 | 83 | 95 | 89 | 83 | 85 | 100 | 95 | 75 | 63 | 78 | 98 |
| Tax % | 25% | 25% | 25% | 26% | 26% | 29% | 23% | 26% | 26% | 26% | 27% | 25% | 25% |
| Net Profit + | 59 | 52 | 63 | 70 | 66 | 59 | 66 | 74 | 70 | 55 | 46 | 58 | 73 |
| EPS in Rs | 5.55 | 4.91 | 5.89 | 6.61 | 6.20 | 5.53 | 6.18 | 6.97 | 6.59 | 5.22 | 4.32 | 5.48 | 6.90 |
Financials of Clean Science & Technology Ltd
Profit & Loss
Annual income statement trend
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 241 | 393 | 419 | 512 | 685 | 936 | 791 | 967 | 957 | 982 |
| Expenses + | 167 | 257 | 234 | 253 | 385 | 533 | 459 | 579 | 601 | 630 |
| Operating Profit | 74 | 137 | 186 | 260 | 300 | 403 | 332 | 388 | 356 | 352 |
| OPM % | 31% | 35% | 44% | 51% | 44% | 43% | 42% | 40% | 37% | 36% |
| Other Income + | 5 | 11 | 11 | 25 | 30 | 30 | 41 | 39 | 32 | 41 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 8 | 11 | 14 | 17 | 25 | 36 | 46 | 69 | 78 | 80 |
| Profit before tax | 70 | 137 | 182 | 267 | 305 | 396 | 326 | 357 | 310 | 313 |
| Tax % | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 26% | 26% | |
| Net Profit + | 49 | 98 | 140 | 198 | 228 | 295 | 244 | 264 | 230 | 233 |
| EPS in Rs | 4.33 | 8.64 | 13.17 | 18.68 | 21.51 | 27.78 | 22.97 | 24.88 | 21.61 | 21.92 |
| Dividend Payout % | 12% | 15% | 2% | 134% | 15% | 18% | 22% | 24% | 28% |
Financials of Clean Science & Technology Ltd
Balance Sheet
Capital structure and asset base
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 186 | 271 | 341 | 529 | 758 | 999 | 1,193 | 1,406 | 1,573 |
| Borrowings + | 1 | 3 | 3 | 0 | 0 | 2 | 2 | 2 | 2 |
| Other Liabilities + | 48 | 53 | 85 | 120 | 156 | 140 | 191 | 181 | 184 |
| Total Liabilities | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 | 1,770 |
| Fixed Assets + | 102 | 127 | 166 | 186 | 296 | 460 | 636 | 715 | 760 |
| CWIP | 2 | 4 | 3 | 55 | 44 | 20 | 57 | 30 | 118 |
| Investments | 18 | 75 | 133 | 232 | 191 | 353 | 339 | 381 | 405 |
| Other Assets + | 114 | 121 | 128 | 187 | 394 | 318 | 364 | 474 | 487 |
| Total Assets | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 | 1,770 |
Financials of Clean Science & Technology Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 45 | 85 | 160 | 193 | 127 | 279 | 236 | 214 | 275 |
| Cash from Investing Activity + | -17 | -94 | -105 | -187 | -79 | -270 | -185 | -152 | -202 |
| Cash from Financing Activity + | -5 | -11 | -55 | -6 | -0 | -55 | -53 | -53 | -64 |
| Net Cash Flow | 23 | -20 | -0 | 0 | 49 | -45 | -2 | 9 | 8 |
| Free Cash Flow | 13 | 46 | 110 | 109 | -12 | 96 | 10 | 72 | 74 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 91% | 88% | 109% | 100% | 65% | 93% | 94% | 80% | 103% |
Financials of Clean Science & Technology Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 55 | 61 | 53 | 82 | 57 | 76 | 77 | 79 |
| Inventory Days | 93 | 79 | 98 | 156 | 143 | 122 | 163 | 156 | 157 |
| Days Payable | 85 | 48 | 101 | 180 | 166 | 90 | 139 | 103 | 118 |
| Cash Conversion Cycle | 69 | 87 | 58 | 29 | 59 | 89 | 99 | 129 | 118 |
| Working Capital Days | 60 | 62 | 33 | 32 | 90 | 68 | 86 | 106 | 110 |
| ROCE % | 59% | 59% | 61% | 47% | 44% | 29% | 27% | 21% |
Guidance history
How Clean Science & Technology Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Flat | Planned | — | — |
| Q4 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q3 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q2 FY26 call → | 10–20% | Flat | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
19 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −29.5% | 23% |
| Last 6 months | −9.6% | 37% |
| Last 3 months | +1.5% | 66% |
The price is 71.5% below its all-time high of ₹2,593.35 (7 Jan 2022). Stocks more than 20% below their peak have their score halved, so 38 became 19.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Clean Science & Technology Ltd: 0.4 × 23 + 0.4 × 37 + 0.2 × 66 = 38, halved to 19 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Clean Science & Technology Ltd's management said in earlier quarters
- Q4 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.